Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
This study is currently recruiting participants.
Verified March 2013 by Sarah Cannon Research Institute
Sponsor:
Sarah Cannon Research Institute
Collaborators:
Prometheus Laboratories
Genentech
Information provided by (Responsible Party):
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT01048099
First received: January 12, 2010
Last updated: March 14, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |